Followers | 237 |
Posts | 10817 |
Boards Moderated | 0 |
Alias Born | 07/17/2006 |
Monday, February 18, 2019 8:52:38 AM
I came to the Vietnam conflict very late...May 1972 and was the last regular army doctor/surgeon to leave on March 31 1973...There were doctors assigned to the embassy, but they were not surgeons...
Vietnam created a lot of myths...When I got back to the USA (CONUS to some "The World" to the GIs)...I was assigned to the USA Academy of Health Sciences...Med-Surg dept...I taught various health care group including surgeons...
Among interesting stats was the 95% in hospital survival rate in Vietnam...I would always ask the incoming surgeons why it was so high..And they would mention helicopters and advanced surgical methods..none of these made any serious contribution...The high in hospital survival rate was entirely the result of the weapons used in the RVN...Both the M-16 used by allied troops and the AK-47 used by the NVA and the Viet Cong were high velocity weapons..These weapons used small 222 cal bullets at velocities over three time the speed of most hand guns..The effect was in the kinetic energy which is velocity squared so a M-16 delivers roughly the energy of a bull hitting you at seventy miles an hour..The local effects are devastating compared to an M-1 used in Korea..The shock wave from an M-16 causes tissue death cms from the bullet path...
The truth is getting hit by a high velocity rifle in any body cavity is going to result in death long before you reach the hospital..If you made it to the hospital..it meant you were not hit in a critical area...
In coming army surgeons were always asking questions about how to deal with liver injuries...Reality we did not deal with liver injuries very often..AK-47 slug hits you in the liver...You're dead..
Years later I remember going to a presentation at the Boston Surgical Society where the discussion was all about using helicopters for auto accidents and other domestic injuries...The speakers always cited the RVN experience...but I knew they never were in the RVN..just REMFs (Rear Echelon Motha Effers to the combat troups)...The army understood it better than these civilian hot shots..and that is if you can't save a trauma victim's life by stopping the bleeding using pressure or a tourniquet and plugging in a IV...Then you are not going to be able to save him unless the injury occurs within a block of the hospital...Then things are going to be tense...Putting up helicopters in an urban area for transportation is not such a good idea...
The last regular army casualty in Vietnam was a helicopter pilot (Scroggins was his name) His chopper was shot down eight hours after the cease fire...I know because he had over 50% third degree burns. I went with him on the Airvac to Okinawa...(My only trip out of country).I don't know whether he made it or not...
My point here is that things are often times, not what they seem at first blush...Vascepa IMO falls on the other side of the equation. That is being more effective than it is perceived by most...With caveats.. The key is the EPA/AA ratio which sets Systemic Inflammation like a thermostat...It is important to understand that EPA is only one half of the equation...AA being the other half..AA levels are set principally by dietary intake of AA which is high in all seed oils (including corn oil) and processed foods that use seed oils to to increase shelf life in modern day super markets...The other dietary factor which raises AA levels is high glycemic index (fast acting) carbs...If you want full benefits from taking Vascepaq...You need to cut down on the AA reeducing agents...The worst of which is probably bread. (something that I am addicted too)...Switch over to Seeded Rye and limit yourself to two slices a day....and your world will improve if you are on V...
":>) JL
Recent AMRN News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 11:30:10 AM
- Amarin Board of Directors Announces CEO Transition • GlobeNewswire Inc. • 06/04/2024 11:30:00 AM
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A. • GlobeNewswire Inc. • 05/28/2024 12:15:23 PM
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/04/2024 10:30:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 01:00:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 12:06:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:05:56 PM
- Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024 • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/12/2024 01:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:31:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:22 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM